Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.8B | 2.8B | 2.8B | 2.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 340.9M | 330.7M | 325.7M | 319.9M |
| Other operating expenses | 0 | 0 | 0 | 0 |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.7B | 1.7B | 1.8B | 1.6B |
| Tax provision | 173.4M | 175.8M | 180.7M | 162.8M |
| Net income | 1.5B | 1.5B | 1.6B | 1.4B |
| Basic EPS | 0.5 | — | 0.6 | 0.6 |
| Diluted EPS | 0.5 | — | 0.6 | 0.6 |
| Basic average shares | 2.5B | — | 2.5B | 2.6B |
| Diluted average shares | 2.5B | — | 2.5B | 2.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.7B | 1.7B | 1.8B | 1.6B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |